Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation

Journal of Bone and Mineral Research

Volumn 13, Issue 5, 1998, Pages 854-862

  Kanatani, Masanori ^a   Sugimoto, Toshitsugu ^a   Takahashi, Yasuyuki ^b   Kaji, Hiroshi ^a   Kitazawa, Riko ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCITRIOL; CYCLIC AMP; ESTROGEN; ESTROGEN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BLAST CELL; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOLYSIS; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CALCITONIN; CELL DIFFERENTIATION; CYCLIC AMP; DNA PRIMERS; ESTRADIOL; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; OSTEOCLASTS; PARATHYROID HORMONE; POLYMERASE CHAIN REACTION; RATS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, CALCITONIN; RECEPTORS, ESTROGEN; RECEPTORS, PARATHYROID HORMONE;

EID: 0031955461     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.5.854     Document Type: Article

References (57)

1. JAMA 1984 National Institutes of Health Consensus Conference. JAMA 252:799-802.
2. Riggs BC, Jowsey J, Goldsmith RS, Kelly PJ, Hoffman DL, Arnoud CD 1972 Short and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest 51:1659-1663.
3. Lafferty FW, Spencer GE, Pearson OH 1964 Effects of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosis. Am J Med 36:514-528.
4. Selby PL, Peacock M, Barkworth SA, Brown WB, Taylor GA 1985 Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. Clin Sci 69:265-271.
5. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR 1989 Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
6. McSheehy PM, Chambers TJ 1986 Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824-828.
7. Thomson BM, Saklatvala J, Chambers TJ 1986 Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 164:104-112.
8. Thomson BM, Mundy GR, Chambers TJ 1987 Tumor necrosis factor α and βinduce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779.
9. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303,
10. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC 1992 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
11. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA 1989 Ovarian steroid treatment blocks a post-menopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
12. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
13. Raisz LG 1988 Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818-828.
14. Horowitz M 1993 Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626-627.
15. Schwartz Soskolone WA, Neubauer T, Goldstein M, Adi S, Ornoy A 1991 Direct and sex-specific enhancement of bone formation and calcification by sex steroids in fetal mice long bone in vitro (biochemical and morphometric study). Endocrinology 129:1167-1174.
16. Caputo CB, Meadows D, Raisz L 1974 Failure of estrogens and androgens to inhibit bone resorption in tissue culture. Endocrinology 98:1065-1068.
17. Liskova M 1976 Influence of estrogen on bone resorption in organ culture. Calcif Tissue Res 22:207-218.
18. 2 and estrogen. Calcif Tissue Int 40:21-26.
19. 43Ca release from embryonic rat bone in vitro. J Pharm Exp Therapeutics 168:211-217.
20. Pilbeam CC, Klein-Nulend J, Raisz LG 1989 Inhibition by 17β-estradiol of PTH stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae. Biochem Biophys Res Commun 163:1319-1324.
21. Atkins D, Zanelli JM, Peacock M, Nordin BEC 1972 The effect of estrogens on the response of bone to parathyroid hormone in vitro. J Endocrinol 54:107-117.
22. Cosman F, Shen V, Herrington BS 1993 A mechanism of estrogen action on the skeleton: Protection against the resorbing effects of (1-34) hPTH infusion as assessed by biochemical markers. Ann Intern Med 118:337-343.
23. Kaji H, Sugimoto T, Kanatani M, Miyauchi A, Kimura T, Sakakibara S, Fukase M, Chihara K 1994 Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity. Endocrinology 134:1897-1904.
24. Hakeda Y, Hiura K, Sato T, Okazaki R, Matsumoto T, Ogata E, Ishitani R, Kumegawa M 1989 Existence of parathyroid hormone binding sites on murine hemopoietic blast cells. Biochem Biophys Res Commun 163:1481-1486.
25. Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Hiura K, Hakeda Y, Kumegawa M 1989 Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74:1295-1302.
26. Akatsu T, Takahashi N, Udagawa N, Sato K, Nagata N, Moseley JM, Martin TJ, Suda T 1989 Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinuclear cell formation to the same extent as PTH in mouse marrow cultures. Endocrinology 125:20-27.
27. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617.
28. Mano H, Yuasa T, Kameda T, Miyazawa K, Nakamura Y, Shiokawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M 1996 Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223:637-642.
29. Fiorelli G, Gori F, Petilli M, Tanini A, Benvenuti S, Serio M, Bernabei P, Brandi ML 1995 Functional estrogen receptors in a human preosteoclastic cell line. Proc Natl Acad Sci USA 92:2672-2676.
30. Kaji H, Sugimoto T, Kanatani M, Nasu M, Chihara K 1996 Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway. Endocrinology 137:2217-2224.
31. Pliam NB, Nyeredy KO, Arnaud CD 1982 Parathyroid hormone receptors in avian bone cells. Proc Natl Acad Sci USA 79:2061-2063.
32. Silve CM, Hradek GT, Jones AL, Arnaud CD 1982 Parathyroid hormone receptor in intact embryonic chicken bone: Characterization and localization. J Cell Biol 94:379-386.
33. Sugimoto T, Kanatani M, Kaji H, Yamaguchi T, Fukase M, Chihara K 1993 Second messenger signaling of PTH- and PTH-related peptide-stimulated osteoclast-like cell formation from mouse hemopoietic blast cells: Role of cAMP-dependent protein kinase and protein kinase C. Am J Physiol 265 (Endocrinol Metab 28):E367-E373.
34. Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yamaguchi A, Nagata N, Suda T 1992 Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res 7:1297-1306.
35. Osdoby P, Martini M, Caplan A 1982 Isolated osteoclasts and their presumed progenitor cell, the monocytes in culture. J Exp Zool 224:331-344.
36. Oursler MJ, Osdoby PC, Anderson F, Li L, Webber D, Osdoby P 1991 Isolation of avian osteoclasts: Improved techniques to preferentially purify viable cells. J Bone Miner Res 6:375-385.
37. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
38. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr, Kronenberg HM, Segre GV 1992 Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2746.
39. White R, Lees JA, Needham M, Ham J, Parker M 1987 Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol 1:735-744.
40. Rosenblatt M, Callahan EN, Mahaffey JE, Pont A, Potts JT Jr 1977 Parathyroid hormone inhibitors: design, synthesis, and biological evaluation of hormone analogues. J Biol Chem 252: 5847-5851.
41. Nakai M, Fukase M, Yamaguchi T, Tsukamoto T, Fujii N, Fujita T 1990 Human PTH(3-34) inhibited the effects of human parathyroid hormone-related protein on phosphate uptake in a cultured renal cell line (OK cells). J Bone Miner Res 5:995-1002.
42. Erisken EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelberg TC, Riggs BL 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86.
43. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Hausler MR 1988 Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-83.
44. Scheven BAA, Damen CA, Hamilton NJ, Verhaar HJJ, Duursma SA 1992 Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biophys Res Commun 186:54-60.
45. Hong MH, Williams H, Jin CH, Pike JW 1994 170-estradiol suppresses mouse osteoclast differentiation and function in vitro via the estrogen receptor. J Bone Miner Res 9 (Suppl): S161 (abstract).
46. Oursler MJ, Pederson L, Fitzpatric L, Riggs L, Speisberg T 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:5227-5231.
47. Reid IR, Civitelli R, Halstead LR, Avioli LV, Hruska KA 1987 Parathyroid hormone acutely elevates intracellular calcium in osteoblast-like cells. Am J Physiol 252 (Endocrinol Metab 15):E45-E52.
48. Civitelli R, Reid IR, Westbrook S, Avioli LV, Hruska KA 1988 PTH elevates inositol polyphosphates and diacylglycerol in rat osteoblast-like cell line. Am J Physiol 255 (Endocrinol Metab 18):E660-E667.
49. Juppner H, Abou-Samra AB, Freeman MW, Kong XF, Schipani E, Richards J, Kolakowski LF, Hock J, Potts JT, Kronenberg HM, Segre GV 1991 A G-protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024-1026.
50. Tam CS, Heersche JNM, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512.
51. Reeve J, Hesp R, Wiliams D, Hulme P, Klenerman L, Zanelli JM, Darby AJ, Tregear GW, Parsons JA 1976 Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1:1035-1038.
52. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R 1993 Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:2479-2487.
53. Gallsgher JC, Nordin BEC 1972 Treatment with oestrogens of primary hyperparathyroidism in post-menopausal women. Lancet 1:503-507.
54. Marcus R, Madvig P, Crim M, Pont A, Kosek J 1984 Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med 100:633-640.
55. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061.
56. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406.
57. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91.